| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | structural constituent of skin epidermis | 7.95e-08 | 43 | 51 | 5 | GO:0030280 | |
| GeneOntologyBiologicalProcess | keratinization | 5.47e-11 | 87 | 53 | 8 | GO:0031424 | |
| GeneOntologyBiologicalProcess | epidermal cell differentiation | SPRR1B SPRR2A SPRR2B SPRR2D SPRR2E GLI2 SPRR2F SPRR2G PITX2 SLITRK6 LCE3C | 1.27e-10 | 284 | 53 | 11 | GO:0009913 |
| GeneOntologyBiologicalProcess | epidermis development | SPRR1B SPRR2A SPRR2B SPRR2D SPRR2E GLI2 SPRR2F SPRR2G PITX2 SLITRK6 LCE3C | 2.02e-08 | 461 | 53 | 11 | GO:0008544 |
| GeneOntologyBiologicalProcess | keratinocyte differentiation | 2.67e-08 | 189 | 53 | 8 | GO:0030216 | |
| GeneOntologyBiologicalProcess | epithelial cell differentiation | SPRR1B SPRR2A SPRR2B SPRR2D SPRR2E GLI2 SPRR2F SPRR2G PITX2 SLITRK6 CDH2 JMJD1C LCE3C | 2.15e-07 | 870 | 53 | 13 | GO:0030855 |
| GeneOntologyBiologicalProcess | skin development | 4.13e-07 | 373 | 53 | 9 | GO:0043588 | |
| GeneOntologyBiologicalProcess | epithelium development | SPRR1B SPRR2A SPRR2B SPRR2D SPRR2E GLI2 SPRR2F SPRR2G PITX2 SLITRK6 CDH2 JMJD1C SMAD1 LCE3C | 1.40e-05 | 1469 | 53 | 14 | GO:0060429 |
| GeneOntologyBiologicalProcess | developmental process involved in reproduction | CFAP47 SPATA31A1 SPATA31A3 GLI2 SPATA31A7 DACH1 AHSG ZDBF2 DZIP1 SPATA31A6 SPATA31A5 JMJD1C | 5.44e-05 | 1235 | 53 | 12 | GO:0003006 |
| GeneOntologyBiologicalProcess | gamete generation | CFAP47 SPATA31A1 SPATA31A3 SPATA31A7 ZDBF2 DZIP1 SPATA31A6 SPATA31A5 FIGNL1 SMAD1 | 1.72e-04 | 982 | 53 | 10 | GO:0007276 |
| GeneOntologyBiologicalProcess | response to estradiol | 3.27e-04 | 128 | 53 | 4 | GO:0032355 | |
| GeneOntologyCellularComponent | cornified envelope | 4.89e-10 | 69 | 54 | 7 | GO:0001533 | |
| GeneOntologyCellularComponent | acrosomal vesicle | 1.48e-05 | 206 | 54 | 6 | GO:0001669 | |
| GeneOntologyCellularComponent | secretory granule | KIAA1210 SPATA31A1 SPATA31A3 SPRR2A SPRR2B SPRR2E SPRR2F SPATA31A7 AHSG SPATA31A6 SPATA31A5 | 4.65e-05 | 1014 | 54 | 11 | GO:0030141 |
| GeneOntologyCellularComponent | secretory vesicle | KIAA1210 SPATA31A1 SPATA31A3 SPRR2A SPRR2B SPRR2E SPRR2F SPATA31A7 AHSG SPATA31A6 SPATA31A5 | 2.88e-04 | 1246 | 54 | 11 | GO:0099503 |
| GeneOntologyCellularComponent | nuclear speck | 8.30e-04 | 431 | 54 | 6 | GO:0016607 | |
| MousePheno | abnormal eye distance/ position | 3.17e-05 | 80 | 32 | 4 | MP:0001299 | |
| Domain | SPRR2 | 3.90e-16 | 6 | 53 | 6 | IPR029142 | |
| Domain | SPRR2 | 3.90e-16 | 6 | 53 | 6 | PF14820 | |
| Domain | SPRR/LCE | 7.20e-15 | 28 | 53 | 8 | IPR026075 | |
| Domain | DUF4599 | 2.81e-08 | 12 | 53 | 4 | PF15371 | |
| Domain | DUF4599 | 2.81e-08 | 12 | 53 | 4 | IPR027970 | |
| Pathway | REACTOME_FORMATION_OF_THE_CORNIFIED_ENVELOPE | 9.64e-10 | 129 | 36 | 8 | M27649 | |
| Pathway | REACTOME_KERATINIZATION | 5.79e-08 | 217 | 36 | 8 | M27640 | |
| Pathway | REACTOME_DEVELOPMENTAL_BIOLOGY | SPRR1B SPRR2A SPRR2B SPRR2D SPRR2E SPRR2F SPRR2G EIF4G1 ZNF638 CDH2 SMAD1 LCE3C | 1.41e-04 | 1432 | 36 | 12 | M509 |
| Pubmed | 1.74e-18 | 10 | 54 | 7 | 8325635 | ||
| Pubmed | 1.14e-17 | 12 | 54 | 7 | 9888996 | ||
| Pubmed | 1.14e-17 | 12 | 54 | 7 | 18643845 | ||
| Pubmed | Estrogen regulates the expression of the small proline-rich 2 gene family in the mouse uterus. | 2.94e-16 | 8 | 54 | 6 | 15232223 | |
| Pubmed | 4.47e-14 | 6 | 54 | 5 | 20850414 | ||
| Pubmed | Targeted disruption of the spermatid-specific gene Spata31 causes male infertility. | 4.47e-14 | 6 | 54 | 5 | 25930072 | |
| Pubmed | Mouse Sprr locus: a tandem array of coordinately regulated genes. | 4.16e-13 | 8 | 54 | 5 | 12584609 | |
| Pubmed | 4.16e-13 | 8 | 54 | 5 | 15574822 | ||
| Pubmed | 9.36e-13 | 9 | 54 | 5 | 11279051 | ||
| Pubmed | 2.59e-11 | 5 | 54 | 4 | 3133554 | ||
| Pubmed | 1.81e-10 | 7 | 54 | 4 | 31884525 | ||
| Pubmed | 3.10e-10 | 24 | 54 | 5 | 32212159 | ||
| Pubmed | 3.62e-10 | 8 | 54 | 4 | 11038185 | ||
| Pubmed | 3.87e-10 | 25 | 54 | 5 | 31410202 | ||
| Pubmed | ZFP750 affects the cutaneous barrier through regulating lipid metabolism. | 1.23e-09 | 31 | 54 | 5 | 37115925 | |
| Pubmed | The mineralocorticoid receptor plays a transient role in mouse skin development. | 3.67e-09 | 13 | 54 | 4 | 26268211 | |
| Pubmed | Novel markers of early ovarian pre-granulosa cells are expressed in an Sry-like pattern. | 5.13e-09 | 14 | 54 | 4 | 19301398 | |
| Pubmed | Amniotic fluid activates the nrf2/keap1 pathway to repair an epidermal barrier defect in utero. | 5.13e-09 | 14 | 54 | 4 | 23237955 | |
| Pubmed | 6.99e-09 | 15 | 54 | 4 | 20880987 | ||
| Pubmed | Expression and regulation of cornified envelope proteins in human corneal epithelium. | 1.41e-08 | 4 | 54 | 3 | 16639001 | |
| Pubmed | 2.47e-08 | 20 | 54 | 4 | 21466799 | ||
| Pubmed | 3.72e-08 | 22 | 54 | 4 | 16949565 | ||
| Pubmed | 3.72e-08 | 22 | 54 | 4 | 24899573 | ||
| Pubmed | 4.51e-08 | 62 | 54 | 5 | 26644517 | ||
| Pubmed | Ovarian development in mice requires the GATA4-FOG2 transcription complex. | 2.95e-07 | 36 | 54 | 4 | 18927154 | |
| Pubmed | 4.55e-07 | 40 | 54 | 4 | 19864314 | ||
| Pubmed | 1.95e-06 | 16 | 54 | 3 | 17767158 | ||
| Pubmed | 2.37e-06 | 2 | 54 | 2 | 28859701 | ||
| Pubmed | 2.37e-06 | 60 | 54 | 4 | 31220272 | ||
| Pubmed | RAB23 coordinates early osteogenesis by repressing FGF10-pERK1/2 and GLI1. | 3.96e-06 | 20 | 54 | 3 | 32662771 | |
| Pubmed | 7.09e-06 | 3 | 54 | 2 | 27464479 | ||
| Pubmed | 7.09e-06 | 3 | 54 | 2 | 9722562 | ||
| Pubmed | Wnt signaling determines ventral spinal cord cell fates in a time-dependent manner. | 7.94e-06 | 25 | 54 | 3 | 18927156 | |
| Pubmed | 1.40e-05 | 197 | 54 | 5 | 32434143 | ||
| Pubmed | 1.42e-05 | 4 | 54 | 2 | 18694874 | ||
| Pubmed | Oct4 links multiple epigenetic pathways to the pluripotency network. | 1.62e-05 | 203 | 54 | 5 | 22083510 | |
| Pubmed | 2.24e-05 | 35 | 54 | 3 | 18676816 | ||
| Pubmed | 2.36e-05 | 5 | 54 | 2 | 24931720 | ||
| Pubmed | 2.36e-05 | 5 | 54 | 2 | 21726547 | ||
| Pubmed | The DNA sequence and biological annotation of human chromosome 1. | SPRR1B SPRR2A SPRR2B SPRR2D SPRR2E SPRR2F SPRR2G GON4L LCE3C | 2.74e-05 | 1031 | 54 | 9 | 16710414 |
| Pubmed | Mesodermal expression of Moz is necessary for cardiac septum development. | 4.94e-05 | 7 | 54 | 2 | 25912687 | |
| Pubmed | BMP7 and SHH regulate Pax2 in mouse retinal astrocytes by relieving TLX repression. | 4.94e-05 | 7 | 54 | 2 | 19505455 | |
| Pubmed | Cnn3 regulates neural tube morphogenesis and neuronal stem cell properties. | 4.94e-05 | 7 | 54 | 2 | 29151265 | |
| Pubmed | Wnt/β-catenin signaling regulates sequential fate decisions of murine cortical precursor cells. | 5.12e-05 | 46 | 54 | 3 | 25182747 | |
| Pubmed | Antagonistic actions of Msx1 and Osr2 pattern mammalian teeth into a single row. | 6.59e-05 | 8 | 54 | 2 | 19251632 | |
| Pubmed | Cdh1 regulates osteoblast function through an APC/C-independent modulation of Smurf1. | 6.59e-05 | 8 | 54 | 2 | 22152476 | |
| Pubmed | 8.46e-05 | 9 | 54 | 2 | 19103752 | ||
| Pubmed | 8.46e-05 | 9 | 54 | 2 | 18816447 | ||
| Pubmed | 8.77e-05 | 55 | 54 | 3 | 28807898 | ||
| Pubmed | 1.14e-04 | 60 | 54 | 3 | 18023262 | ||
| Pubmed | 1.29e-04 | 11 | 54 | 2 | 28239148 | ||
| Pubmed | Mechanical feedback defines organizing centers to drive digit emergence. | 1.29e-04 | 11 | 54 | 2 | 35413235 | |
| Pubmed | Sonic hedgehog signaling directs patterned cell remodeling during cranial neural tube closure. | 1.29e-04 | 11 | 54 | 2 | 33103996 | |
| Pubmed | 1.34e-04 | 733 | 54 | 7 | 34672954 | ||
| Pubmed | Intraflagellar Transport Complex B Proteins Regulate the Hippo Effector Yap1 during Cardiogenesis. | 1.55e-04 | 12 | 54 | 2 | 32698004 | |
| Pubmed | 1.72e-04 | 69 | 54 | 3 | 30352686 | ||
| Pubmed | 1.83e-04 | 13 | 54 | 2 | 19631205 | ||
| Pubmed | 1.83e-04 | 13 | 54 | 2 | 18550712 | ||
| Pubmed | 1.83e-04 | 13 | 54 | 2 | 33144400 | ||
| Pubmed | Lrp4 modulates extracellular integration of cell signaling pathways in development. | 2.13e-04 | 14 | 54 | 2 | 19116665 | |
| Pubmed | Roles of Bmp4 during tooth morphogenesis and sequential tooth formation. | 2.13e-04 | 14 | 54 | 2 | 23250216 | |
| Pubmed | 2.13e-04 | 14 | 54 | 2 | 19783738 | ||
| Pubmed | 2.13e-04 | 14 | 54 | 2 | 26912663 | ||
| Pubmed | 2.45e-04 | 15 | 54 | 2 | 38517430 | ||
| Pubmed | 2.45e-04 | 15 | 54 | 2 | 10098408 | ||
| Pubmed | 2.45e-04 | 15 | 54 | 2 | 24912677 | ||
| Pubmed | 2.45e-04 | 15 | 54 | 2 | 24780629 | ||
| Pubmed | 2.45e-04 | 15 | 54 | 2 | 22547067 | ||
| Pubmed | Creation of genome-wide protein expression libraries using random activation of gene expression. | 2.63e-04 | 367 | 54 | 5 | 11329013 | |
| Pubmed | Nucleoredoxin sustains Wnt/β-catenin signaling by retaining a pool of inactive dishevelled protein. | 3.17e-04 | 17 | 54 | 2 | 20970343 | |
| Pubmed | 3.17e-04 | 17 | 54 | 2 | 18667074 | ||
| Pubmed | 3.17e-04 | 17 | 54 | 2 | 18521945 | ||
| Pubmed | MOZ directs the distal-less homeobox gene expression program during craniofacial development. | 3.17e-04 | 17 | 54 | 2 | 31340933 | |
| Pubmed | 3.17e-04 | 17 | 54 | 2 | 18832393 | ||
| Pubmed | Tgif1 and Tgif2 regulate Nodal signaling and are required for gastrulation. | 3.17e-04 | 17 | 54 | 2 | 20040491 | |
| Pubmed | 3.56e-04 | 18 | 54 | 2 | 32105214 | ||
| Pubmed | 3.56e-04 | 18 | 54 | 2 | 17601530 | ||
| Pubmed | Threshold-specific requirements for Bmp4 in mandibular development. | 3.56e-04 | 18 | 54 | 2 | 15936012 | |
| Pubmed | 3.98e-04 | 19 | 54 | 2 | 18981480 | ||
| Pubmed | alphaE-catenin controls cerebral cortical size by regulating the hedgehog signaling pathway. | 3.98e-04 | 19 | 54 | 2 | 16543460 | |
| Pubmed | 3.98e-04 | 19 | 54 | 2 | 34988124 | ||
| Pubmed | Probing transcription-specific outputs of β-catenin in vivo. | 3.98e-04 | 19 | 54 | 2 | 22190459 | |
| Pubmed | 4.42e-04 | 20 | 54 | 2 | 30570432 | ||
| Pubmed | MOZ regulates the Tbx1 locus, and Moz mutation partially phenocopies DiGeorge syndrome. | 4.42e-04 | 20 | 54 | 2 | 22921202 | |
| Pubmed | 4.42e-04 | 20 | 54 | 2 | 29412136 | ||
| Pubmed | Glycoproteomics Reveals Decorin Peptides With Anti-Myostatin Activity in Human Atrial Fibrillation. | 4.70e-04 | 97 | 54 | 3 | 27559042 | |
| Pubmed | Control of lens development by Lhx2-regulated neuroretinal FGFs. | 4.88e-04 | 21 | 54 | 2 | 27633990 | |
| Pubmed | 4.88e-04 | 21 | 54 | 2 | 24198274 | ||
| Pubmed | 4.88e-04 | 21 | 54 | 2 | 32855417 | ||
| Pubmed | 4.88e-04 | 21 | 54 | 2 | 38402586 | ||
| Pubmed | A census of human transcription factors: function, expression and evolution. | 4.92e-04 | 908 | 54 | 7 | 19274049 | |
| Pubmed | Multiplexed kinase interactome profiling quantifies cellular network activity and plasticity. | 4.98e-04 | 910 | 54 | 7 | 36736316 | |
| Pubmed | The STUbL RNF4 regulates protein group SUMOylation by targeting the SUMO conjugation machinery. | 5.07e-04 | 1203 | 54 | 8 | 29180619 | |
| Pubmed | 5.36e-04 | 22 | 54 | 2 | 17919533 | ||
| Pubmed | 5.36e-04 | 22 | 54 | 2 | 38794925 | ||
| Pubmed | 5.36e-04 | 22 | 54 | 2 | 14645517 | ||
| Pubmed | Rap1 controls epiblast morphogenesis in sync with the pluripotency states transition. | 5.86e-04 | 23 | 54 | 2 | 35998584 | |
| Pubmed | 5.86e-04 | 23 | 54 | 2 | 30779601 | ||
| Pubmed | 5.86e-04 | 23 | 54 | 2 | 30814516 | ||
| Pubmed | Differentially expressed late constituents of the epidermal cornified envelope. | 5.86e-04 | 23 | 54 | 2 | 11698679 | |
| Interaction | PTK6 interactions | 2.16e-07 | 104 | 50 | 6 | int:PTK6 | |
| Cytoband | 1q21-q22 | 5.02e-16 | 23 | 54 | 7 | 1q21-q22 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr1q21 | 1.09e-09 | 404 | 54 | 9 | chr1q21 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr9q12 | 3.79e-05 | 8 | 54 | 2 | chr9q12 | |
| Cytoband | 9p13.1 | 3.69e-04 | 24 | 54 | 2 | 9p13.1 | |
| Cytoband | 3q27 | 4.00e-04 | 25 | 54 | 2 | 3q27 | |
| GeneFamily | Small proline rich proteins | 2.19e-17 | 11 | 36 | 7 | 1353 | |
| GeneFamily | PWWP domain containing | 8.68e-04 | 22 | 36 | 2 | 1147 | |
| GeneFamily | PHD finger proteins | 1.38e-02 | 90 | 36 | 2 | 88 | |
| Coexpression | HUMMERICH_BENIGN_SKIN_TUMOR_UP | 6.52e-08 | 20 | 52 | 4 | MM491 | |
| Coexpression | HUMMERICH_MALIGNANT_SKIN_TUMOR_UP | 1.19e-07 | 23 | 52 | 4 | MM492 | |
| Coexpression | MARTINEZ_RB1_TARGETS_UP | 1.36e-05 | 741 | 52 | 9 | MM1037 | |
| Coexpression | GSE29164_UNTREATED_VS_CD8_TCELL_TREATED_MELANOMA_DAY7_DN | 4.78e-05 | 200 | 52 | 5 | M8496 | |
| Coexpression | MARTINEZ_RB1_AND_TP53_TARGETS_UP | 5.93e-05 | 689 | 52 | 8 | MM1041 | |
| Coexpression | MARTINEZ_TP53_TARGETS_UP | 6.24e-05 | 694 | 52 | 8 | MM1039 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-6689_k-means-cluster#3_top-relative-expression-ranked_1000 | 5.52e-07 | 196 | 53 | 7 | DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-6689_k3_1000 | |
| CoexpressionAtlas | esophagus | 3.39e-05 | 247 | 53 | 6 | esophagus | |
| CoexpressionAtlas | JC_iEC_top-relative-expression-ranked_2500_k-means-cluster#4 | 4.36e-05 | 382 | 53 | 7 | JC_iEC_2500_K4 | |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Floor Plate_top-relative-expression-ranked_1000_k-means-cluster#1 | 4.41e-05 | 259 | 53 | 6 | Facebase_RNAseq_e8.5_Floor Plate_1000_K1 | |
| CoexpressionAtlas | DevelopingKidney_e14.5 whole kidney - Wnt4 KO_emap-6674_k-means-cluster#5_top-relative-expression-ranked_1000 | 7.94e-05 | 288 | 53 | 6 | gudmap_developingKidney_e14.5 whole kidney - Wnt4 KO_1000_k5 | |
| CoexpressionAtlas | DevelopingKidney_e14.5 whole kidney - Wnt4 KO_emap-6674_k-means-cluster#3_top-relative-expression-ranked_500 | 1.05e-04 | 188 | 53 | 5 | gudmap_developingKidney_e14.5 whole kidney - Wnt4 KO_500_k3 | |
| CoexpressionAtlas | Progenitor-Cell-Biology-Consortium_reference_BronchioEpithel_top-relative-expression-ranked_100 | 1.05e-04 | 98 | 53 | 4 | PCBC_ctl_BronchioEpithel_100 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ Genital tubercle F_emap-6706_k-means-cluster#1_top-relative-expression-ranked_1000 | 1.19e-04 | 193 | 53 | 5 | gudmap_developingLowerUrinaryTract_e14.5_ Genital tubercle F_1000_k1 | |
| ToppCell | TCGA-Head_and_Esophagus|World / Sample_Type by Project: Shred V9 | 1.61e-09 | 172 | 54 | 7 | eb18aa179db1818f408c38e442ecfed8582d7dbc | |
| ToppCell | PSB-critical-LOC-Epithelial-Squamous|LOC / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 2.47e-09 | 183 | 54 | 7 | 2cf798a2371c61322484ea16fdfae0acfa94f102 | |
| ToppCell | NS-moderate-d_07-13|moderate / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 3.84e-09 | 195 | 54 | 7 | 088209505a68519ec89f50f0576096da6966bf17 | |
| ToppCell | Smart-seq2-tissue-resident_(Smart-seq2)-myeloid-myeloid_monocytic|tissue-resident_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 3.98e-09 | 196 | 54 | 7 | 03de28e1c963e99623e8b0e33bf2e8ef67dc3baa | |
| ToppCell | Smart-seq2-tissue-resident_(Smart-seq2)-myeloid-myeloid_monocytic-leukocyte|tissue-resident_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 4.13e-09 | 197 | 54 | 7 | e621d4f9d4ba5e3ef17d2b477e5e14ea0251147e | |
| ToppCell | 10x_3'_v3-tissue-resident_(10x_3'_v3)-myeloid-myeloid_monocytic|tissue-resident_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 4.13e-09 | 197 | 54 | 7 | 7870c0651caefb0ed13d9f9dab43b5f24d6a9efc | |
| ToppCell | 10x_3'_v3-tissue-resident_(10x_3'_v3)-myeloid-myeloid_monocytic-leukocyte|tissue-resident_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 4.13e-09 | 197 | 54 | 7 | d968d7d5608b175bb567ea3a315bf473ec3be459 | |
| ToppCell | NS-moderate-d_07-13-Epithelial-Squamous|d_07-13 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 4.27e-09 | 198 | 54 | 7 | b7495369baba203490c067a58fc8456a778a12e4 | |
| ToppCell | Bronchial_Brush-Epithelial-Ciliated_2|Bronchial_Brush / Tissue, Lineage and Cell class of Lung Cells from 10X | 1.31e-08 | 132 | 54 | 6 | 780a391924f776dc6fbe44ddcf4ae0583a1e2157 | |
| ToppCell | Bronchial_Brush-Epithelial-Ciliated_2|Epithelial / Tissue, Lineage and Cell class of Lung Cells from 10X | 1.50e-08 | 135 | 54 | 6 | 366a417f9ef7c0d86e9f262d97bf788f478315ee | |
| ToppCell | TCGA-Bladder-Primary_Tumor-Urothelial_Carcinoma-Non-Papillary_Muscle_Invasive_Urothelial_Carcinoma-6|TCGA-Bladder / Sample_Type by Project: Shred V9 | 6.13e-08 | 171 | 54 | 6 | 0e78389f8f3d54570a6deb3dd307b865b46307e9 | |
| ToppCell | 3'-Airway_Nasal-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)-Goblet_(nasal)_L.0.2.0.3|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 8.04e-08 | 179 | 54 | 6 | 2b5f8e109a67c7fc3ec2b83e8f1854160c99283a | |
| ToppCell | TCGA-Skin-Primary_Tumor|TCGA-Skin / Sample_Type by Project: Shred V9 | 1.14e-07 | 190 | 54 | 6 | e2b26a03c6ab24d9b0f4150c47597be37767d86e | |
| ToppCell | TCGA-Skin-Primary_Tumor-Melanoma|TCGA-Skin / Sample_Type by Project: Shred V9 | 1.14e-07 | 190 | 54 | 6 | 01fb45add4661bc86cd0a34fac35177907152dbb | |
| ToppCell | TCGA-Skin-Primary_Tumor-Melanoma-Skin_Cutaneous_Melanoma|TCGA-Skin / Sample_Type by Project: Shred V9 | 1.14e-07 | 190 | 54 | 6 | 3188c7bd225cbcf46a21e2fb784336cdd9665995 | |
| ToppCell | NS-moderate-d_16-33-Epithelial-Squamous|d_16-33 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 1.22e-07 | 192 | 54 | 6 | 103496f428f59683ac3ae6147682c07c30663724 | |
| ToppCell | NS-critical-d_07-13-Epithelial-Squamous|d_07-13 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 1.29e-07 | 194 | 54 | 6 | 53a34843d529ef395deb27086f71f7049a087bab | |
| ToppCell | critical-Epithelial-Squamous|Epithelial / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 1.42e-07 | 197 | 54 | 6 | cfbdaada7169afb68455724ae87032ff311b2d89 | |
| ToppCell | NS-control-d_0-4-Epithelial-Squamous|d_0-4 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 1.42e-07 | 197 | 54 | 6 | ab965a0ba87efd3329d24a1ec123985f46fc17c0 | |
| ToppCell | moderate-Epithelial-Squamous|moderate / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 1.42e-07 | 197 | 54 | 6 | ab3c90a5b643b45d0b83939c6304b11f567c5d78 | |
| ToppCell | critical-Epithelial-Squamous|critical / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 1.42e-07 | 197 | 54 | 6 | eccc80d6ab79c46b10108de1cff3abeacfc105cd | |
| ToppCell | moderate-Epithelial-Squamous|Epithelial / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 1.42e-07 | 197 | 54 | 6 | 2e13881f917d4f62a5b3e968e41c57e43300d988 | |
| ToppCell | TCGA-Brain-Primary_Tumor-Low_Grade_Glioma-Oligoastrocytoma-2|TCGA-Brain / Sample_Type by Project: Shred V9 | 7.33e-07 | 139 | 54 | 5 | 6f6c64eaa1ce84e0aa9a0caa9c4d9bf7afe626df | |
| ToppCell | Bronchial_Biopsy-Epithelial-Goblet_2|Bronchial_Biopsy / Tissue, Lineage and Cell class of Lung Cells from 10X | 1.18e-06 | 153 | 54 | 5 | b25629953ff79aff645845376132b12023067b01 | |
| ToppCell | Bronchial_Biopsy-Epithelial-Goblet_2|Epithelial / Tissue, Lineage and Cell class of Lung Cells from 10X | 1.18e-06 | 153 | 54 | 5 | e9d6b4e895ddb8d6e6c8b043da591ec11365e124 | |
| ToppCell | Ciliated_cells-A-Donor_01|World / lung cells shred on cell class, cell subclass, sample id | 1.61e-06 | 163 | 54 | 5 | 43194c6127df1ce3d29242f719645de3c11fd7c0 | |
| ToppCell | NS-moderate-d_0-4-Epithelial-Squamous|d_0-4 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 1.92e-06 | 169 | 54 | 5 | 4a5d023ffcf83312d29b1d215eb6b744ef1a0777 | |
| ToppCell | nucseq-Mesenchymal-Fibroblastic-Fibroblastic_1-Mesothelial|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 2.41e-06 | 177 | 54 | 5 | 0912a291cff32a4ff8a2d7680ed1a1cd867fb90f | |
| ToppCell | NS|World / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 2.62e-06 | 180 | 54 | 5 | 8472dcce7bc0b7ce428ec17ddf0018f3258f78d2 | |
| ToppCell | tumor_Lung-Fibroblasts-Mesothelial_cells|tumor_Lung / Location, Cell class and cell subclass | 2.91e-06 | 184 | 54 | 5 | b0a251030d127858e68cf164be158f209a4d720f | |
| ToppCell | TCGA-Skin-Primary_Tumor-Melanoma-Skin_Cutaneous_Melanoma-6|TCGA-Skin / Sample_Type by Project: Shred V9 | 3.15e-06 | 187 | 54 | 5 | 2ca7928baf0c5e61f7294ed05e6e6f0e0adf9d3f | |
| ToppCell | wk_15-18-Mesenchymal-Mesothelial-Late_mesothelial|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 3.24e-06 | 188 | 54 | 5 | 38a53f99f1876359983936403aefca93281d10fd | |
| ToppCell | tumor_Lung-Fibroblasts-Mesothelial_cells|Fibroblasts / Location, Cell class and cell subclass | 3.41e-06 | 190 | 54 | 5 | d82ab67735c1f365d4b0e02b5fa91c64cdc234da | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Epithelial_transtional-secretory-club_cell-Club_(nasal)-Club_(nasal)_L.0.2.3.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.49e-06 | 191 | 54 | 5 | 529068029fb461df766135576dd0d8b5980f9bc0 | |
| ToppCell | NS-critical-d_0-4-Epithelial-Squamous|d_0-4 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 3.77e-06 | 194 | 54 | 5 | 614d0c25b56957c70f397abb169fd2a860eb1c06 | |
| ToppCell | NS-critical-d_16-33-Epithelial-Squamous|d_16-33 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 3.96e-06 | 196 | 54 | 5 | 97e16d9833e4083d719ca7058d5fc9b11edb37e3 | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Airway_epithelium-respiratory_basal_cell|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.06e-06 | 197 | 54 | 5 | fb272c9c60ee3d980e528044dc567b4925a23da6 | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Airway_epithelium-respiratory_basal_cell-Suprabasal-Suprabasal_L.0.0.2.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.06e-06 | 197 | 54 | 5 | 2430f31d9312338e0ca23bfc6bdb0365340860fd | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Airway_epithelium|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.06e-06 | 197 | 54 | 5 | 61c0d78b29dc4ad8a84172cbfcdab03f31351d0e | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Airway_epithelium-respiratory_basal_cell-Suprabasal|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.06e-06 | 197 | 54 | 5 | dcabea5c50c133c9a4e294e447462d0393174ea7 | |
| ToppCell | control-Epithelial-Squamous|control / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 4.17e-06 | 198 | 54 | 5 | 6ba669ac1ed275ae309054941b1457e315766faa | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Airway_epithelium-respiratory_basal_cell-Suprabasal-Suprabasal_L.0.0.2.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.17e-06 | 198 | 54 | 5 | e06d41a7254a09e037ec404be2d8c352d5cbd7f4 | |
| ToppCell | control-Epithelial-Squamous|Epithelial / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 4.27e-06 | 199 | 54 | 5 | e13dca7a055cdca53dd6c26c04b2a46d58b419b6 | |
| ToppCell | TCGA-Breast-Primary_Tumor-Breast_Carcinoma-Metaplastic_Carcinoma-2|TCGA-Breast / Sample_Type by Project: Shred V9 | 4.79e-06 | 92 | 54 | 4 | cad8b1b74a412988b2ae4f6126b2186100a2cdc2 | |
| ToppCell | TCGA-Breast-Primary_Tumor-Breast_Carcinoma-Ductal_and_Metaplastic_Carcinoma|TCGA-Breast / Sample_Type by Project: Shred V9 | 1.51e-05 | 123 | 54 | 4 | 51e49a64fbbf77e2ee21f45fd515d43282b11516 | |
| ToppCell | TCGA-Breast-Primary_Tumor-Breast_Carcinoma-Ductal_and_Metaplastic_Carcinoma-4|TCGA-Breast / Sample_Type by Project: Shred V9 | 1.51e-05 | 123 | 54 | 4 | 11802979943a9205f10facda322fc220d4bf7133 | |
| ToppCell | TCGA-Bone_and_Soft_Tissue-Primary_Tumor-Sarcoma-Undifferentiated_Pleomorphic_Sarcoma-4|TCGA-Bone_and_Soft_Tissue / Sample_Type by Project: Shred V9 | 1.94e-05 | 131 | 54 | 4 | 2ccf679b5035b7b9cdb9a9a660cad90288592187 | |
| ToppCell | TCGA-Stomach-Primary_Tumor-Stomach_Adenocarcinoma-Stomach_Adenocarcinoma_-_NOS-4|TCGA-Stomach / Sample_Type by Project: Shred V9 | 4.56e-05 | 163 | 54 | 4 | 6a12b802cb181f979ebc72674f3626fb855024e3 | |
| ToppCell | BAL-Mild-Myeloid-MoAM-MoAM5-|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 4.89e-05 | 166 | 54 | 4 | 006ced12f69ef13ddcba5a3891ddc7c18c384863 | |
| ToppCell | Bronchial_Brush-Epithelial-Goblet_2|Bronchial_Brush / Tissue, Lineage and Cell class of Lung Cells from 10X | 4.89e-05 | 166 | 54 | 4 | 8ac0a769be886d16642e7e6334471ebadd1a426b | |
| ToppCell | BAL-Mild-Myeloid-MoAM-MoAM5|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 4.89e-05 | 166 | 54 | 4 | ac28c8cac1e94be0c47fb862c5809c92cdaa11f3 | |
| ToppCell | BAL-Mild-Myeloid-MoAM-MoAM5-|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 4.89e-05 | 166 | 54 | 4 | 6bb3410e65c971acc458c472015afcec6de6e310 | |
| ToppCell | Control-Epithelial-Mesothelial|Control / Disease state, Lineage and Cell class | 4.89e-05 | 166 | 54 | 4 | 1ed3788257e14f097862b999f020bfe2a57de52b | |
| ToppCell | BAL-Mild-Myeloid-MoAM-MoAM5|Mild / Location, Disease Group, Cell group, Cell class (2021.03.09) | 4.89e-05 | 166 | 54 | 4 | 823ec03714884cb860a1260410feac8c536b6d06 | |
| ToppCell | Bronchial_Brush-Epithelial-Goblet_2|Epithelial / Tissue, Lineage and Cell class of Lung Cells from 10X | 5.01e-05 | 167 | 54 | 4 | 806d1c00c137da0c5f042adf866873eb6dd4bb27 | |
| ToppCell | normal_Lung-Fibroblasts-Mesothelial_cells|Fibroblasts / Location, Cell class and cell subclass | 5.01e-05 | 167 | 54 | 4 | 892a2dc83ab5de5a1016402f8e95d2aabf651326 | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)-Glut_CT2_L6_FEZF2|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 5.13e-05 | 168 | 54 | 4 | 217770a94ace446cdfc7687b459dece707576e76 | |
| ToppCell | Adult-Endothelial-endothelial_cell_of_artery-D231|Adult / Lineage, Cell type, age group and donor | 5.13e-05 | 168 | 54 | 4 | aca34c51758c65925ad24110294a72b2dea6db72 | |
| ToppCell | 3'-Distal_airway-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)-Goblet_(nasal)_L.0.2.0.3|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.37e-05 | 170 | 54 | 4 | 13a225e32132e9717debb0d64d7c28ada974c3e6 | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)-Goblet_(nasal)_L.0.2.2.2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.88e-05 | 174 | 54 | 4 | 207aa0118633cbe9a65839bbb1bb3ba9f8118ad2 | |
| ToppCell | PND01-Endothelial-Endothelial_lymphatic-Lymphatic_EC-LEC-LEC_prolif|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 6.14e-05 | 176 | 54 | 4 | a9e77681bcd36c382d53eb6f771349d55f98d744 | |
| ToppCell | TCGA-Lung-Primary_Tumor-Lung_Carcinoma-Lung_Squamous_Cell_Carcinoma-5|TCGA-Lung / Sample_Type by Project: Shred V9 | 6.28e-05 | 177 | 54 | 4 | a0c7d08469c513cecf87777c19876884f1511570 | |
| ToppCell | P28-Epithelial-epithelial_progenitor_cell-epithelial_unknown_3|P28 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 6.70e-05 | 180 | 54 | 4 | 1e819c5c87704ec6535dfeaae56561895e239d07 | |
| ToppCell | droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_D_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.70e-05 | 180 | 54 | 4 | 8bf6e8b6b45ce42f8c5f23e7cd1752ec8b3fa2d2 | |
| ToppCell | droplet-Kidney-nan-3m-Mesenchymal-podocyte|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.85e-05 | 181 | 54 | 4 | 0b1e7335648823b1d83bdfa878ccd44efe7bba9a | |
| ToppCell | facs-Trachea-24m-Epithelial-glandular_epithelial|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 7.30e-05 | 184 | 54 | 4 | 61caaa31975e05c9a6512079c791fed5a9e2d39f | |
| ToppCell | facs-Trachea-24m-Epithelial-glandular_epithelial-lung_secretory_cell|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 7.30e-05 | 184 | 54 | 4 | 03da0f0f89f1ca5a3ccca1e22972f3129464e68e | |
| ToppCell | facs-Trachea-24m-Epithelial-glandular_epithelial-lung_secretory_cell-mucous|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 7.30e-05 | 184 | 54 | 4 | 9ed2a65a4ca0ebbbb89ace61027522f93369843d | |
| ToppCell | droplet-Marrow-nan-3m|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.30e-05 | 184 | 54 | 4 | 1154a5ad7b8512272b7476f949ddac350910bfb7 | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)-Goblet_(nasal)_L.0.2.0.3|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 7.45e-05 | 185 | 54 | 4 | f3fbc3096f85397a959cee17c3c4fcf2d511f3d5 | |
| ToppCell | cellseq-Mesenchymal-Fibroblastic-Fibroblastic_1-Mesothelial|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 7.61e-05 | 186 | 54 | 4 | 7812ed80d2378aca9957ef22fc3c8fb7fb58434b | |
| ToppCell | LV-10._Endothelium_II|World / Chamber and Cluster_Paper | 7.77e-05 | 187 | 54 | 4 | 7876dcb4800c2e54874df3d933efb79307a64a97 | |
| ToppCell | SupraBC-Differ-KC|World / shred by cell class for mouse tongue | 8.10e-05 | 189 | 54 | 4 | 6412741b88e241304033b41effca0c77a374d907 | |
| ToppCell | COVID-19-Heart-EC_1|COVID-19 / Disease (COVID-19 only), tissue and cell type | 8.10e-05 | 189 | 54 | 4 | fe49852ba15f948b384d6b4c258927c70b741357 | |
| ToppCell | TCGA-Lung-Primary_Tumor-Lung_Carcinoma-Lung_Squamous_Cell_Carcinoma|TCGA-Lung / Sample_Type by Project: Shred V9 | 8.10e-05 | 189 | 54 | 4 | aa4f7d7a5196e5ae481ebc2549de8e3f0ef6e6be | |
| ToppCell | BL-critical-LOC-Epithelial-Squamous|LOC / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 8.43e-05 | 191 | 54 | 4 | 3f9b8c4fb72ae6f3167b187e6715c4dcb3159f98 | |
| ToppCell | wk_15-18-Mesenchymal-Mesothelial|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 8.43e-05 | 191 | 54 | 4 | b5374674312ff5803a1d369f5533027532344679 | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)-Goblet_(nasal)_L.0.2.0.3|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 8.43e-05 | 191 | 54 | 4 | fbd8d337b4444fba8527a614e4a8bfb516ce0f66 | |
| ToppCell | 3'-Airway_Nasal-Epithelial-Airway_epithelium-respiratory_basal_cell-Suprabasal-Suprabasal_L.0.0.2.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 8.60e-05 | 192 | 54 | 4 | 24fb2f1e6f49ab5b71876e105c0ee7f59e7d64e8 | |
| ToppCell | droplet-Tongue-Unstain-18m-Epithelial-suprabasal|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.78e-05 | 193 | 54 | 4 | f074ebf9c5c53d8589d66b0109505f30baa1af81 | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Fibro-meso|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 8.95e-05 | 194 | 54 | 4 | f4286ae7bb8350c42d50727ee8688b80129714f6 | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Fibro-meso-mesothelial_cell|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 8.95e-05 | 194 | 54 | 4 | 87461bd6d7f702c0a0f5e0c8ace3049125a51f9a | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Fibro-meso-mesothelial_cell-Mesothelium|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 8.95e-05 | 194 | 54 | 4 | c578cf7c6b4d6f31f87dde8845de5b3891f16822 | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Epithelial-Epithelial,_Airway-squamous_epithelial_cell|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 9.13e-05 | 195 | 54 | 4 | 82d87fdb39ec15be9057e2d2ba5c1afb5f97aafe | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Epithelial-Epithelial,_Airway-squamous_epithelial_cell-Epi-Squamous|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 9.13e-05 | 195 | 54 | 4 | dd8117dbd22892288f74a7314ab0b5080106936c | |
| ToppCell | 3'-Child04-06-SmallIntestine-Endothelial-blood_vessel_EC-Mature_venous_EC|Child04-06 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 9.13e-05 | 195 | 54 | 4 | 527a5a50d6e2cbbbd64d11609e5cde2e33f14797 | |
| ToppCell | ILEUM-non-inflamed-(9)_Neuro_cell|non-inflamed / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 9.32e-05 | 196 | 54 | 4 | 2b08cd6730119d5dea0152709ab8de580b66cd3c | |
| ToppCell | NS-critical-LOC-Epithelial-Squamous|LOC / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 9.32e-05 | 196 | 54 | 4 | 453c809494ceffa2a28af283c4b5a4924fcf160f | |
| ToppCell | ILEUM-non-inflamed-(9)_Enteric_neurons|non-inflamed / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 9.32e-05 | 196 | 54 | 4 | 998aa523555ed6bc9c1b5cacbf7ba77c7b218e6b | |
| ToppCell | 3'-GW_trimst-1-SmallIntestine-Mesenchymal-mesothelial_cell-Mesothelium|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 9.32e-05 | 196 | 54 | 4 | 147dc1ca5942df48a083cce39a9a7541430f8365 | |
| ToppCell | COPD-Epithelial-Club|Epithelial / Disease state, Lineage and Cell class | 9.32e-05 | 196 | 54 | 4 | af96fb94886e9395f3e2cd0a293af29229d017fe | |
| ToppCell | 5'-Adult-LargeIntestine-Endothelial-blood_vessel_EC-Mature_venous_EC|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 9.50e-05 | 197 | 54 | 4 | 87eda06344498dc66cac292cf89746dc90b5cf67 | |
| ToppCell | 356C-Endothelial_cells|356C / Donor, Lineage, Cell class and subclass (all cells) | 9.50e-05 | 197 | 54 | 4 | f20eda534b2b28986790b28ce150ca3ba067593a | |
| ToppCell | Parenchymal-10x5prime-Stromal-Mesofibroblastic|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 9.50e-05 | 197 | 54 | 4 | 88a86286b9c3ea3b076d7464faec42d0392ee7f8 | |
| ToppCell | Parenchymal-10x5prime-Stromal-Mesofibroblastic-Mesothelia|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 9.50e-05 | 197 | 54 | 4 | 2773d2eb5f232a7e49da116efffcb6bf5eb90810 | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Epithelial-Epithelial,_Airway|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 9.50e-05 | 197 | 54 | 4 | ac9c0c25cfeaabd53d332982c73fc6c47b0c6478 | |
| ToppCell | LV-09._Endothelium_I|LV / Chamber and Cluster_Paper | 9.50e-05 | 197 | 54 | 4 | f9731d4d636e51b94a96805eee6afe9aedc175e3 | |
| ToppCell | distal-Epithelial-Basal-1|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 9.50e-05 | 197 | 54 | 4 | 75b4292ce2ad7f9c8b6a4781e1cb71f5b18b74e3 | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Epithelial|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 9.50e-05 | 197 | 54 | 4 | b57d2e3413ef6dd1da56c45087926f2f3eab876c | |
| ToppCell | Biopsy_Other_PF-Mesenchymal-Mesothelial_cells|Biopsy_Other_PF / Sample group, Lineage and Cell type | 9.69e-05 | 198 | 54 | 4 | 86736f01e61bf4961f060b24ee1f1f48340737dd | |
| Drug | 4-tert-octylphenol | 5.51e-08 | 159 | 50 | 7 | ctd:C105260 | |
| Disease | Paroxysmal atrial fibrillation | 1.22e-04 | 156 | 48 | 4 | C0235480 | |
| Disease | familial atrial fibrillation | 1.22e-04 | 156 | 48 | 4 | C3468561 | |
| Disease | Persistent atrial fibrillation | 1.22e-04 | 156 | 48 | 4 | C2585653 | |
| Disease | Atrial Fibrillation | 1.35e-04 | 160 | 48 | 4 | C0004238 | |
| Disease | phosphatidylcholine 34:4 measurement | 1.69e-04 | 12 | 48 | 2 | EFO_0010378 | |
| Disease | level of C-X-C motif chemokine 2 in blood serum | 1.69e-04 | 12 | 48 | 2 | OBA_2041207 | |
| Disease | level of C-X-C motif chemokine 3 in blood serum | 2.68e-04 | 15 | 48 | 2 | OBA_2041208 | |
| Disease | atrial fibrillation | 3.36e-04 | 371 | 48 | 5 | EFO_0000275 | |
| Disease | Anophthalmia-microphthalmia syndrome | 5.34e-04 | 21 | 48 | 2 | cv:C5680330 | |
| Disease | cortical thickness change measurement, age at assessment | 6.41e-04 | 23 | 48 | 2 | EFO_0008007, EFO_0021501 | |
| Disease | monocyte count | 1.20e-03 | 1320 | 48 | 8 | EFO_0005091 | |
| Disease | ascending aortic diameter | 1.55e-03 | 140 | 48 | 3 | EFO_0021787 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| ATHCTPLPAQNFQMP | 541 | O95870 | |
| CPFQAPNVSSMISNL | 691 | Q8NFM4 | |
| PCQLPFPSTMQQHSP | 376 | Q8IY63 | |
| TVQAMQPPSQAPAQD | 616 | O43246 | |
| NSCAQDPASFMPPQQ | 1476 | Q6UB98 | |
| MPPQQPCSFPSQSLS | 1486 | Q6UB98 | |
| PSPVENTPQNNECKM | 176 | Q9UI36 | |
| QPCACPLTNPENMFS | 1611 | P98160 | |
| MQGPNLSNPCASPQV | 211 | Q02930 | |
| QNAQPPMVTNTARTC | 186 | Q6PIW4 | |
| ISLCMPESQQQNTPP | 1966 | Q15652 | |
| EQITPQQPVMNCYQT | 1491 | Q2LD37 | |
| SMSYQAPPQQLPSAQ | 151 | Q96PV6 | |
| ISQPQFTAMNEPQCF | 11 | Q92633 | |
| MTCENQNPCFPIQLP | 261 | P07202 | |
| CQVMRSQPPQPQACQ | 1466 | P10070 | |
| MCAVLSPPPQPSSNQ | 796 | A8MYU2 | |
| PQQQPPLSQCSMNNS | 1696 | Q92794 | |
| PLSQCSMNNSFTPAP | 1701 | Q92794 | |
| TCMVFQTQPVSSQPQ | 246 | P02765 | |
| QQSMDPTAFPVPTFQ | 856 | O95886 | |
| CNMIQPVNAAVAQSP | 1161 | Q3T8J9 | |
| PQATQMNTPSQPRQH | 36 | Q04637 | |
| QGQSTIPCPANNNPM | 996 | Q9P267 | |
| SRCPSQPIMNPTVQQ | 911 | Q9ULL0 | |
| NIATSPQSPLMQCSF | 116 | O60381 | |
| MSCQQNQQQCQPPPS | 1 | Q5T5A8 | |
| SNNMPPICVQNTPKV | 1721 | Q6ZTR5 | |
| QAPSTPSPNMFTINN | 311 | P19022 | |
| CPGLVNNPSMPTQTS | 566 | Q9H5Y7 | |
| PSNPCLDTSQNQPSM | 286 | Q5H9M0 | |
| QSPPFLFNEMSNVCP | 441 | Q5VVP1 | |
| QSPPFLFNEMSNVCP | 441 | Q8IWB4 | |
| MQQSQVQLQCPLTPP | 766 | Q96PQ0 | |
| NVNPLSSQSMFSPPN | 201 | Q99697 | |
| NPNPGQSVSVVCPME | 391 | O15079 | |
| QAFESQPAAPAVPMN | 461 | Q86YF9 | |
| MPLNATFPDSFQQPN | 166 | Q15797 | |
| QPSSPPNQCANVMAG | 1301 | Q8NFU7 | |
| QSPPFLFNEMSNVCP | 441 | Q5VYP0 | |
| NFSVSQVPNMPSCPQ | 366 | Q9NZ09 | |
| MVQAQVPNQTCPNTV | 141 | Q14587 | |
| QSPPFLFNEMSNVCP | 441 | Q5TZJ5 | |
| QSPPFLFNEMSNVCP | 441 | Q5VU36 | |
| PQTPPILSMNAFFNN | 56 | Q6NW29 | |
| MSSQQQKQPCTPPPQ | 1 | P22528 | |
| MSYQQQQCKQPCQPP | 1 | P35326 | |
| MSYQQQQCKQPCQPP | 1 | P35325 | |
| MSYQQQQCKQPCQPP | 1 | P22532 | |
| MSYQQQQCKQPCQPP | 1 | P22531 | |
| MSYQQQQCKQPCQPP | 1 | Q96RM1 | |
| MSYQQQQCKQPCQPP | 1 | Q9BYE4 | |
| NVPPQSMTDQPQLAF | 1046 | Q9HCK1 | |
| PVLDSNDPNFQMPCS | 66 | Q92576 | |
| MSFSEQQCKQPCVPP | 1 | Q5T870 | |
| NNSSVSPPQQMPYNV | 216 | Q96SE7 | |
| MCDQQKQPQFPPSCV | 1 | Q5T750 | |
| SVPNPNVICNSMFPV | 251 | Q14966 |